SK scores vital win in patent dispute with Moderna - The Pharma Letter

SK scores vital win in patent dispute with Moderna  The Pharma Letter

SK bioscience wins patent case against Moderna in Korea - Korea JoongAng Daily

SK bioscience wins patent case against Moderna in Korea  Korea JoongAng Daily

What to Expect From Moderna's Q1 2025 Earnings Report - Nasdaq

What to Expect From Moderna's Q1 2025 Earnings Report  Nasdaq

Where Will Moderna Be in 5 Years? - The Motley Fool

Where Will Moderna Be in 5 Years?  The Motley Fool

TD Cowen Adjusts Moderna Price Target to $30 From $35, Maintains Hold Rating - marketscreener.com

TD Cowen Adjusts Moderna Price Target to $30 From $35, Maintains Hold Rating  marketscreener.com

The Gutierrez Co. Sued Over Mold, Water Damage at Moderna Site — Boston Business Journal - Boston...

The Gutierrez Co. Sued Over Mold, Water Damage at Moderna Site — Boston Business Journal  Boston Real Estate Times

Moderna sues construction firm claiming leaks, mold at new drug plant - NBC Boston

Moderna sues construction firm claiming leaks, mold at new drug plant  NBC Boston

Cautious Outlook: Moderna’s Revenue and EPS Projections Lead to Hold Rating and Lowered Price Tar...

Cautious Outlook: Moderna’s Revenue and EPS Projections Lead to Hold Rating and Lowered Price Target  TipRanks

Moderna (MRNA) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance

Moderna (MRNA) Stock Drops Despite Market Gains: Important Facts to Note  Yahoo Finance

More Downside For Moderna Before The Breakthrough (NASDAQ:MRNA) - Seeking Alpha

More Downside For Moderna Before The Breakthrough (NASDAQ:MRNA)  Seeking Alpha

SK Bioscience Wins Patent Invalidation Case Against Moderna - Businesskorea

SK Bioscience Wins Patent Invalidation Case Against Moderna  Businesskorea

Moderna (NASDAQ:MRNA) Given Market Perform Rating at William Blair - MarketBeat

Moderna (NASDAQ:MRNA) Given Market Perform Rating at William Blair  MarketBeat

SK bioscience defeats Moderna in patent dispute in Korea, clears path for mRNA vaccine - koreabio...

SK bioscience defeats Moderna in patent dispute in Korea, clears path for mRNA vaccine  koreabiomed.com

Moderna advances pandemic preparedness agenda with UK clearance for commercial mRNA vaccine plant...

Moderna advances pandemic preparedness agenda with UK clearance for commercial mRNA vaccine plant  Fierce Pharma

SK bioscience wins patent case against Moderna in South Korea - The Hans India

SK bioscience wins patent case against Moderna in South Korea  The Hans India

Moderna Sues Construction Firm Over Alleged Defects In Production Facility - Bisnow

Moderna Sues Construction Firm Over Alleged Defects In Production Facility  Bisnow

Moderna: Fair Value Lowered on ‘Hostile’ FDA Environment - Morningstar

Moderna: Fair Value Lowered on ‘Hostile’ FDA Environment  Morningstar

Moderna Can't Buy Time To Defend COVID Vax UPC Claim - Law360

Moderna Can't Buy Time To Defend COVID Vax UPC Claim  Law360

Lobbying Update: $60,000 of MODERNA INC. lobbying was just disclosed - Nasdaq

Lobbying Update: $60,000 of MODERNA INC. lobbying was just disclosed  Nasdaq

Natixis Purchases 49,953 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Natixis Purchases 49,953 Shares of Moderna, Inc. (NASDAQ:MRNA)  MarketBeat

Is Moderna Stock A Sell After The FDA's 'Bloodbath?' - Investor's Business Daily

Is Moderna Stock A Sell After The FDA's 'Bloodbath?'  Investor's Business Daily

Study estimates current Moderna vaccine 53% effective against COVID hospitalization - CIDRAP

Study estimates current Moderna vaccine 53% effective against COVID hospitalization  CIDRAP

Canada Pension Plan Investment Board Raises Stock Position in Moderna, Inc. (NASDAQ:MRNA) - Marke...

Canada Pension Plan Investment Board Raises Stock Position in Moderna, Inc. (NASDAQ:MRNA)  MarketBeat

Moderna (NasdaqGS:MRNA) Takes 17% Hit Amid Global Trade Concerns - Yahoo Finance

Moderna (NasdaqGS:MRNA) Takes 17% Hit Amid Global Trade Concerns  Yahoo Finance

SK bioscience invalidates Moderna's mRNA patent, accelerates vaccine trials - CHOSUNBIZ - Chosunbiz

SK bioscience invalidates Moderna's mRNA patent, accelerates vaccine trials - CHOSUNBIZ  Chosunbiz

Is Moderna, Inc. (MRNA) the Best Gene-Editing Stock to Buy? - Yahoo Finance

Is Moderna, Inc. (MRNA) the Best Gene-Editing Stock to Buy?  Yahoo Finance

I had the Moderna vaccine and have been bedbound with mystery fatigue ever since - it's ruined my...

I had the Moderna vaccine and have been bedbound with mystery fatigue ever since - it's ruined my life  Daily Mail

S&P 500 Gains and Losses Today: Moderna Stock Plunges After Resignation of FDA Vaccine Official -...

S&P 500 Gains and Losses Today: Moderna Stock Plunges After Resignation of FDA Vaccine Official  Investopedia

As Vaccine Skepticism Mounts, Moderna’s Business Grows More Precarious - Barron's

As Vaccine Skepticism Mounts, Moderna’s Business Grows More Precarious  Barron's

Watch These Moderna Price Levels as Stock Sinks to 5-Year Low - Investopedia

Watch These Moderna Price Levels as Stock Sinks to 5-Year Low  Investopedia

Moderna brand chief Kate Cronin leaves for 'next chapter' - Fierce Pharma

Moderna brand chief Kate Cronin leaves for 'next chapter'  Fierce Pharma

Why Moderna Stock Is Plummeting Today - Yahoo Finance

Why Moderna Stock Is Plummeting Today  Yahoo Finance

Moderna’s UK plant granted MHRA green light - BioProcess International

Moderna’s UK plant granted MHRA green light  BioProcess International

Moderna (NasdaqGS:MRNA) Faces Legal Spotlight Affecting Investor Sentiment with -8% Dip Over Last...

Moderna (NasdaqGS:MRNA) Faces Legal Spotlight Affecting Investor Sentiment with -8% Dip Over Last Month  Yahoo Finance

Moderna, Inc. - Britannica

Moderna, Inc.  Britannica

Vaccine-wary Slovak PM pauses COVID-19 shot purchases pending review - marketscreener.com

Vaccine-wary Slovak PM pauses COVID-19 shot purchases pending review  marketscreener.com

Moderna surprises the Street by predicting a bigger-than-expected sales drop - AP News

Moderna surprises the Street by predicting a bigger-than-expected sales drop  AP News

Jim Cramer Slams Moderna, Inc. (MRNA) as One of the Year’s Biggest Disappointments - Yahoo Finance

Jim Cramer Slams Moderna, Inc. (MRNA) as One of the Year’s Biggest Disappointments  Yahoo Finance

USPTO Finds Claims of Two of Moderna’s mRNA Patents Unpatentable: What’s Next in the Vaccine Wars...

USPTO Finds Claims of Two of Moderna’s mRNA Patents Unpatentable: What’s Next in the Vaccine Wars?  Crowell & Moring LLP

Moderna Stock Falls as FDA Vaccine Chief Resigns, Citing RFK Jr.'s 'Misinformation' - Investopedia

Moderna Stock Falls as FDA Vaccine Chief Resigns, Citing RFK Jr.'s 'Misinformation'  Investopedia

Why Moderna (MRNA) Stock Is Rallying Today - Yahoo Finance

Why Moderna (MRNA) Stock Is Rallying Today  Yahoo Finance

Better Beaten-Down Stock to Buy: Pfizer Vs. Moderna - The Motley Fool

Better Beaten-Down Stock to Buy: Pfizer Vs. Moderna  The Motley Fool

UK health regulator approves Moderna's RSV vaccine for adults aged 60 and older - Reuters

UK health regulator approves Moderna's RSV vaccine for adults aged 60 and older  Reuters

Why Moderna, Inc. (MRNA) Went Up on Wednesday - Yahoo Finance

Why Moderna, Inc. (MRNA) Went Up on Wednesday  Yahoo Finance

Moderna shoulders $238M contract manufacturing cancellation charge in Q4 - Fierce Pharma

Moderna shoulders $238M contract manufacturing cancellation charge in Q4  Fierce Pharma

Moderna COVID Vaccine Technology Struck Down by PTAB - IPWatchdog.com

Moderna COVID Vaccine Technology Struck Down by PTAB  IPWatchdog.com

Moderna, biotech stocks slide following resignation of FDA official Peter Marks - Yahoo Finance

Moderna, biotech stocks slide following resignation of FDA official Peter Marks  Yahoo Finance

Moderna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. ...

Moderna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says 'wishes subservient confirmation of his misinformation and lies'  Fortune

Jim Cramer: Moderna (MRNA) Blew It – But Their Cash Pile Could Save Them! - Yahoo Finance

Jim Cramer: Moderna (MRNA) Blew It – But Their Cash Pile Could Save Them!  Yahoo Finance

Bridgewater Associates LP Makes New Investment in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Bridgewater Associates LP Makes New Investment in Moderna, Inc. (NASDAQ:MRNA)  MarketBeat

Moderna (NasdaqGS:MRNA) Sees 15% Jump Despite Recent Revenue Challenges - Yahoo Finance

Moderna (NasdaqGS:MRNA) Sees 15% Jump Despite Recent Revenue Challenges  Yahoo Finance

Here's Why Moderna Stock Soared 16% on Wednesday - Yahoo Finance

Here's Why Moderna Stock Soared 16% on Wednesday  Yahoo Finance

Scotia Capital Inc. Has $284,000 Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Scotia Capital Inc. Has $284,000 Holdings in Moderna, Inc. (NASDAQ:MRNA)  MarketBeat

Why Moderna (MRNA) Went Up on Tuesday? - Yahoo Finance

Why Moderna (MRNA) Went Up on Tuesday?  Yahoo Finance

Why Moderna (MRNA) Stock Is Up Today - Yahoo Finance

Why Moderna (MRNA) Stock Is Up Today  Yahoo Finance

Trump administration weighs pulling funding for Moderna bird flu vaccine, Bloomberg News reports ...

Trump administration weighs pulling funding for Moderna bird flu vaccine, Bloomberg News reports  Reuters

Moderna Stock: Is MRNA Underperforming the Healthcare Sector? - Nasdaq

Moderna Stock: Is MRNA Underperforming the Healthcare Sector?  Nasdaq

Moderna Stock Trades Near 52-Week Low: Should You Buy, Hold or Sell? - Yahoo Finance

Moderna Stock Trades Near 52-Week Low: Should You Buy, Hold or Sell?  Yahoo Finance

U.S. pays $590 million to Moderna to speed up development of bird flu vaccine - NPR

U.S. pays $590 million to Moderna to speed up development of bird flu vaccine  NPR

Moderna, Inc. (MRNA): Among Stocks To Trade Without Tariffs And Interest Rate Fears - Yahoo Finance

Moderna, Inc. (MRNA): Among Stocks To Trade Without Tariffs And Interest Rate Fears  Yahoo Finance

Why Moderna Stock Has Surged 15% This Week Despite Mixed News - Investor's Business Daily

Why Moderna Stock Has Surged 15% This Week Despite Mixed News  Investor's Business Daily

Moderna shares tumble on slashed sales guidance - BioPharma Dive

Moderna shares tumble on slashed sales guidance  BioPharma Dive

Moderna (NasdaqGS:MRNA) Up 11% Despite Patent Lawsuit Challenges - Yahoo Finance

Moderna (NasdaqGS:MRNA) Up 11% Despite Patent Lawsuit Challenges  Yahoo Finance

Moderna picks Merck KGaA, Roivant alum as marketing chief - Fierce Pharma

Moderna picks Merck KGaA, Roivant alum as marketing chief  Fierce Pharma

Moderna Stock Falls on Earnings Report. The Results Reaffirm a Grim Picture for Vaccine Maker. - ...

Moderna Stock Falls on Earnings Report. The Results Reaffirm a Grim Picture for Vaccine Maker.  Barron's

Moderna Posts Wider-Than-Expected Q4 Loss, 2025 Sales Outlook Disappoints - Investopedia

Moderna Posts Wider-Than-Expected Q4 Loss, 2025 Sales Outlook Disappoints  Investopedia

Why Moderna Stock Was Down 31.8% in Q1 as the S&P 500 Had Its Worst Quarter Since 2022 - Yahoo Fi...

Why Moderna Stock Was Down 31.8% in Q1 as the S&P 500 Had Its Worst Quarter Since 2022  Yahoo Finance

Moderna's $590M US contract for bird flu jab is on ice: report - FirstWord Pharma

Moderna's $590M US contract for bird flu jab is on ice: report  FirstWord Pharma

Moderna mpox mRNA vaccine shows early promise in monkey study - Clinical Trials Arena

Moderna mpox mRNA vaccine shows early promise in monkey study  Clinical Trials Arena

Behind Moderna’s Quiet Gamble on China - WSJ - WSJ

Behind Moderna’s Quiet Gamble on China - WSJ  WSJ

Analysts Set Moderna, Inc. (NASDAQ:MRNA) Target Price at $58.70 - MarketBeat

Analysts Set Moderna, Inc. (NASDAQ:MRNA) Target Price at $58.70  MarketBeat

S&P 500 Gains and Losses Today: Moderna Stock Pops as Execs Buy Shares, Express Cancer Vaccine Op...

S&P 500 Gains and Losses Today: Moderna Stock Pops as Execs Buy Shares, Express Cancer Vaccine Optimism  Investopedia

Trump team weighs pulling funding for Moderna's bird flu shot despite outbreak - Axios

Trump team weighs pulling funding for Moderna's bird flu shot despite outbreak  Axios

Moderna (MRNA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release - Yahoo Finance

Moderna (MRNA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release  Yahoo Finance

Moderna cuts sales forecast on weaker vaccine demand - Yahoo Finance

Moderna cuts sales forecast on weaker vaccine demand  Yahoo Finance

Trump HHS reevaluating Biden administration's $590M bird flu vaccine contract with Moderna: Bloom...

Trump HHS reevaluating Biden administration's $590M bird flu vaccine contract with Moderna: Bloomberg  Fierce Biotech

Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks - Yahoo Finance

Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks  Yahoo Finance

Moderna Eyes 2027 Launch for Cancer Vaccine Developed With Merck - Bloomberg.com

Moderna Eyes 2027 Launch for Cancer Vaccine Developed With Merck  Bloomberg.com

Moderna stock forfeits gains as first US bird flu death puts vaccine development in focus - Yahoo...

Moderna stock forfeits gains as first US bird flu death puts vaccine development in focus  Yahoo Finance

Why Are Analysts Bullish on Moderna, Inc. (MRNA) Now? - Yahoo Finance

Why Are Analysts Bullish on Moderna, Inc. (MRNA) Now?  Yahoo Finance

Trump’s Hammer Hits FDA, Moderna Falls Further and Patent Cliffs Loom - BioSpace

Trump’s Hammer Hits FDA, Moderna Falls Further and Patent Cliffs Loom  BioSpace

Should You Buy, Hold or Sell Moderna Stock Post Q4 Earnings Release? - Yahoo Finance

Should You Buy, Hold or Sell Moderna Stock Post Q4 Earnings Release?  Yahoo Finance

Why Moderna (MRNA) Crashed on Wednesday? - Yahoo Finance

Why Moderna (MRNA) Crashed on Wednesday?  Yahoo Finance

Moderna beats on revenue but loses more than expected as it scales down manufacturing - CNBC

Moderna beats on revenue but loses more than expected as it scales down manufacturing  CNBC

Moderna CEO Stéphane Bancel scored pay bump in 2024 despite revenue decline and missed sales targ...

Moderna CEO Stéphane Bancel scored pay bump in 2024 despite revenue decline and missed sales target  Fierce Pharma

Moderna norovirus vaccine trial on hold by US FDA over neurological side effect - Reuters

Moderna norovirus vaccine trial on hold by US FDA over neurological side effect  Reuters

Moderna (MRNA) Advances But Underperforms Market: Key Facts - Yahoo Finance

Moderna (MRNA) Advances But Underperforms Market: Key Facts  Yahoo Finance

Trump Team Weighs Pulling Funding for Moderna Bird Flu Vaccine - Bloomberg.com

Trump Team Weighs Pulling Funding for Moderna Bird Flu Vaccine  Bloomberg.com

HHS awards $590 million to Moderna to develop mRNA vaccines against pandemic flu threats - CIDRAP

HHS awards $590 million to Moderna to develop mRNA vaccines against pandemic flu threats  CIDRAP

As bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic influenza...

As bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic influenza vaccines  Fortune

Moderna and Other Vaccine Stocks Climb Amid Concerns About Coronavirus Study in China - Investopedia

Moderna and Other Vaccine Stocks Climb Amid Concerns About Coronavirus Study in China  Investopedia

Moderna, Inc. (MRNA): Among Stocks with Potential to Explode in 2025 - Yahoo Finance

Moderna, Inc. (MRNA): Among Stocks with Potential to Explode in 2025  Yahoo Finance

Why Moderna, Inc. (MRNA) Went Down on Tuesday - Yahoo Finance

Why Moderna, Inc. (MRNA) Went Down on Tuesday  Yahoo Finance

Moderna says it’s ‘one step closer’ to a norovirus vaccine as the virus spreads across the U.S. -...

Moderna says it’s ‘one step closer’ to a norovirus vaccine as the virus spreads across the U.S.  Fortune

COVID-19 vaccine maker Moderna eyes mRNA manufacturing efficiencies as 3 plants set to come onlin...

COVID-19 vaccine maker Moderna eyes mRNA manufacturing efficiencies as 3 plants set to come online in 2025  BioProcess International

Arbutus, Genevant expand COVID patent feud with Moderna with 5 international lawsuits - Fierce Ph...

Arbutus, Genevant expand COVID patent feud with Moderna with 5 international lawsuits  Fierce Pharma

Moderna’s norovirus vaccine trial placed on FDA hold over reported case of Guillain-Barré syndrom...

Moderna’s norovirus vaccine trial placed on FDA hold over reported case of Guillain-Barré syndrome  Fierce Biotech

Empowering the next generation: Moderna’s free course on mRNA medicines - Science | AAAS

Empowering the next generation: Moderna’s free course on mRNA medicines  Science | AAAS

‘Safety signal’ in Moderna’s RSV vaccine studies halts trials of other vaccines for childhood kil...

‘Safety signal’ in Moderna’s RSV vaccine studies halts trials of other vaccines for childhood killer  Science | AAAS

Moderna, Inc. (MRNA): A Bull Case Theory - Yahoo Finance

Moderna, Inc. (MRNA): A Bull Case Theory  Yahoo Finance